Infectious Diseases (except HIV/AIDS)

  1. SARS-CoV-2 Neutralizing Antibodies in Chile after a Vaccination Campaign with Five Different Schemes

    1. Ximena Aguilera
    2. Juan Hormazábal
    3. Cecilia Vial
    4. Lina Jimena Cortes
    5. Claudia González
    6. Paola Rubilar
    7. Mauricio Apablaza
    8. Muriel Ramírez-Santana
    9. Gloria Icaza
    10. Loreto Nuñez-Franz
    11. Carla Castillo-Laborde
    12. Carolina Ramírez-Riffo
    13. Claudia Pérez
    14. Rubén Quezada-Gate
    15. Macarena Said
    16. Pablo Vial

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Development and evaluation of low-volume tests to detect and characterise antibodies to SARS-CoV-2

    1. Alice Halliday
    2. Anna E Long
    3. Holly E Baum
    4. Amy C Thomas
    5. Kathryn L Shelley
    6. Elizabeth Oliver
    7. Kapil Gupta
    8. Ore Francis
    9. Maia Kavanagh Williamson
    10. Natalie di Bartolo
    11. Matthew J Randell
    12. Yassin Ben-Khoud
    13. Ilana Kelland
    14. Georgina Mortimer
    15. Olivia Ball
    16. Charlie Plumptre
    17. Kyla Chandler
    18. Ulrike Obst
    19. Massimiliano Secchi
    20. Lorenzo Piemonti
    21. Vito Lampasona
    22. Joyce Smith
    23. Michaela Gregorova
    24. Lea Knezevic
    25. Jane Metz
    26. Rachael Barr
    27. Begonia Morales-Aza
    28. Jennifer Oliver
    29. Lucy Collingwood
    30. Benjamin Hitchings
    31. Susan Ring
    32. Linda Wooldridge
    33. Laura Rivino
    34. Nicholas Timpson
    35. Jorgen McKernon
    36. Peter Muir
    37. Fergus Hamilton
    38. David Arnold
    39. Derek N Woolfson
    40. Anu Goenka
    41. Andrew D. Davidson
    42. Ashley M Toye
    43. Imre Berger
    44. Mick Bailey
    45. Kathleen M Gillespie
    46. Alistair JK Williams
    47. Adam Finn

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. SARS-COV-2 antibody responses to AZD1222 vaccination in West Africa

    1. Adam Abdullahi
    2. David Oladele
    3. Michael Owusu
    4. Steven A. Kemp
    5. James Ayorinde
    6. Abideen Salako
    7. Douglas Fink
    8. Fehintola Ige
    9. Isabella A. T. M. Ferreira
    10. Bo Meng
    11. Augustina Angelina Sylverken
    12. Chika Onwuamah
    13. Kwame Ofori Boadu
    14. Kazeem Osuolale
    15. James Opoku Frimpong
    16. Rufai Abubakar
    17. Azuka Okuruawe
    18. Haruna Wisso Abdullahi
    19. Gideon Liboro
    20. Lawrence Duah Agyemang
    21. Nana Kwame Ayisi-Boateng
    22. Oluwatosin Odubela
    23. Gregory Ohihoin
    24. Oliver Ezechi
    25. Japhet Senyo Kamasah
    26. Emmanuel Ameyaw
    27. Joshua Arthur
    28. Derrick Boakye Kyei
    29. Dorcas Ohui Owusu
    30. Olagoke Usman
    31. Sunday Mogaji
    32. Adedamola Dada
    33. George Agyei
    34. Soraya Ebrahimi
    35. Lourdes Ceron Gutierrez
    36. Sani H. Aliyu
    37. Rainer Doffinger
    38. Rosemary Audu
    39. Richard Adegbola
    40. Petra Mlcochova
    41. Richard Odame Phillips
    42. Babatunde Lawal Solako
    43. Ravindra K. Gupta

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Durability of Immune Response After COVID-19 Booster Vaccination and Association With COVID-19 Omicron Infection

    1. Mayan Gilboa
    2. Gili Regev-Yochay
    3. Michal Mandelboim
    4. Victoria Indenbaum
    5. Keren Asraf
    6. Ronen Fluss
    7. Sharon Amit
    8. Ella Mendelson
    9. Ram Doolman
    10. Arnon Afek
    11. Laurence S. Freedman
    12. Yitshak Kreiss
    13. Yaniv Lustig

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. UB-612, a Multitope Universal Vaccine Eliciting a Balanced B and T Cell Immunity against SARS-CoV-2 Variants of Concern

    1. Chang Yi Wang
    2. Kao-Pin Hwang
    3. Hui-Kai Kuo
    4. Be-Sheng Kuo
    5. Hope Liu
    6. Kuo-Liang Hou
    7. Wan-Yu Tsai
    8. Han-Chen Chiu
    9. Yu-Hsin Ho
    10. Jennifer Cheng
    11. Min-Sheng Wang
    12. Ya-Ting Yang
    13. Po-Yen Chang
    14. Yea-Huei Shen
    15. Wen-Jiun Peng

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Epstein–Barr virus (EBV) deletions as biomarkers of response to treatment of chronic active EBV

    1. Cristina Venturini
    2. Charlotte J. Houldcroft
    3. Arina Lazareva
    4. Fanny Wegner
    5. Sofia Morfopoulou
    6. Persis J. Amrolia
    7. Zainab Golwala
    8. Anupama Rao
    9. Stephen D. Marks
    10. Jacob Simmonds
    11. Tetsushi Yoshikawa
    12. Paul J. Farrell
    13. Jeffrey I. Cohen
    14. Austen J. Worth
    15. Judith Breuer

    • Curated by eLife

      Evaluation Summary:

      The author present a large amount of sequencing data of EBV present in a variety of individuals, including a few with the interesting and unusual disease manifestation known as Chronic Active EBV (CAEV). The data show that there is a great deal of heterogeneity in the EBV genomes among people and overtime in some individuals, but the data do not reveal any particular mechanistic insights about the importance of this heterogeneity and the sample size is too small to warrant use of these deletions as therapeutic biomarkers.

      (This preprint has been reviewed by eLife. We include the public reviews from the reviewers here; the authors also receive private feedback with suggested changes to the manuscript. Reviewer #3 agreed to share their name with the authors.)

    Reviewed by eLife

    4 evaluationsAppears in 1 listLatest version Latest activity

  7. Accident and emergency (AE) attendance in England following infection with SARS-CoV-2 Omicron or Delta

    1. Daniel J. Grint
    2. Kevin Wing
    3. Hamish P. Gibbs
    4. Stephen JW Evans
    5. Elizabeth Williamson
    6. Krishnan Bhaskaran
    7. Helen I McDonald
    8. Alex J. Walker
    9. David Evans
    10. George Hickman
    11. Rohini Mathur
    12. Anna Schultze
    13. Christopher T Rentsch
    14. John Tazare
    15. Ian J Douglas
    16. Helen J. Curtis
    17. Caroline E Morton
    18. Sebastian Bacon
    19. Simon Davy
    20. Brian MacKenna
    21. Peter Inglesby
    22. Richard Croker
    23. John Parry
    24. Frank Hester
    25. Sam Harper
    26. Nicholas J DeVito
    27. Will Hulme
    28. Chris Bates
    29. Jonathon Cockburn
    30. Amir Mehrkar
    31. Ben Goldacre
    32. Rosalind M. Eggo
    33. Laurie Tomlinson

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. SARS-CoV-2 outbreaks in secondary school settings in the Netherlands during fall 2020; silent circulation

    1. Lotte Jonker
    2. Kimberly J. Linde
    3. Marieke L. A. de Hoog
    4. Robin Sprado
    5. Robin C. Huisman
    6. Richard Molenkamp
    7. Bas B. Oude Munnink
    8. Wietske Dohmen
    9. Dick J. J. Heederik
    10. Dirk Eggink
    11. Matthijs R. A. Welkers
    12. Harry Vennema
    13. Pieter L. A. Fraaij
    14. Marion P. G. Koopmans
    15. Inge M. Wouters
    16. Patricia C. J. L. Bruijning-Verhagen

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. An early return-to-work program for COVID-19 close contacts in healthcare during the Omicron wave in Japan

    1. Hiroyuki Naruse
    2. Yohei Doi
    3. Mitsunaga Iwata
    4. Kiyohito Ishikawa

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Immunogenicity and reactogenicity of a third dose of BNT162b2 vaccine for COVID-19 after a primary regimen with BBIBP-CorV or BNT162b2 vaccines in Lima, Peru

    1. Natalia Vargas-Herrera
    2. Manuel Fernández-Navarro
    3. Nestor E. Cabezudo
    4. Percy Soto-Becerra
    5. Gilmer Solís-Sánchez
    6. Stefan Escobar-Agreda
    7. Javier Silva-Valencia
    8. Luis Pampa-Espinoza
    9. Ricardo Bado-Pérez
    10. Lely Solari
    11. Roger V. Araujo-Castillo

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 164 of 716 Next